Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dorottya Godor"'
Publikováno v:
Patient Preference and Adherence. 14:1669-1682
The increasing use of advanced biologic therapies for patients with severe asthma is transforming the standard of care, clinic workflow, and the clinic business model. Expanded patient access to at-home injection treatment possibilities with some bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10c8697e577d951ceea84cb2c7c09aea
https://doi.org/10.2147/ppa.s227465
https://doi.org/10.2147/ppa.s227465
Autor:
Reika, Miyokawa, Celeste, Kivler, Samuel, Louie, Dorottya, Godor, Laren, Tan, Nicholas, Kenyon
Publikováno v:
Patient preference and adherence
The increasing use of advanced biologic therapies for patients with severe asthma is transforming the standard of care, clinic workflow, and the clinic business model. Expanded patient access to at-home injection treatment possibilities with some bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44120f4fb75e9f47d2d9a5ea284ed5c0
https://pubmed.ncbi.nlm.nih.gov/33061310
https://pubmed.ncbi.nlm.nih.gov/33061310
Autor:
Erika Godor, Dorottya Godor
Publikováno v:
Chemistry ISBN: 9781315229324
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c5f4bd145a5d0bb4ee8efd14ed56e8d
https://doi.org/10.1201/9781315229324-8
https://doi.org/10.1201/9781315229324-8
Autor:
Dorottya Godor, Arshiya Mastan, Dalila AbdRahman, Terry O'Shaughnessy, Vladimir Macavei, Nilaani Murugesu
Publikováno v:
Noninvasive Ventilatory Support.
Introduction: Non-Invasive Ventilation (NIV) has become a widespread tool in the management of acute hypercapnic respiratory failure (AHRF). Due to the recent update of British Thoracic Society (BTS) NIV guidelines (1) it is essential to review our p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac03dd61819f82b174c20e10a461ea60
https://doi.org/10.1183/1393003.congress-2017.pa2156
https://doi.org/10.1183/1393003.congress-2017.pa2156
Publikováno v:
Journal of Asthma and Allergy
Tan, LD; Bratt, JM; Godor, D; Louie, S; & Kenyon, NJ. (2016). Benralizumab: A unique IL-5 inhibitor for severe asthma. Journal of Asthma and Allergy, 9, 71-81. doi: 10.2147/JAA.S78049. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/4w7302z0
Tan, LD; Bratt, JM; Godor, D; Louie, S; & Kenyon, NJ. (2016). Benralizumab: A unique IL-5 inhibitor for severe asthma. Journal of Asthma and Allergy, 9, 71-81. doi: 10.2147/JAA.S78049. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/4w7302z0
© 2016 Tan et al. The presence of eosinophilic inflammation is a characteristic feature of chronic and acute inflammation in asthma. An estimated 5%-10% of the 300 million people worldwide who suffer from asthma have a severe form. Patients with eos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e9a6a2704c548733e0cf71bd91debe
https://escholarship.org/uc/item/4w7302z0
https://escholarship.org/uc/item/4w7302z0